Please assess the completion status of the following clinical trial:

Trial Title: Tiotropium / Respimat One-Year Study

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: 3.0

Eligibility Criteria:
None

- Gender: ALL
- Minimum Age: 40 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Tiotropium Respimat 5mcg (Tio R5) (Type: OTHER): None
- Tiotropium Respimat 10mcg (Tio R10) (Type: OTHER): None
- Placebo (Type: OTHER): None

Based on this trial design, predict the completion outcome and termination type (if applicable).